GLP-1ClinicsNearMe

Weight Loss Clinics in Providence, Rhode Island

Looking for a weight loss clinic that prescribes GLP-1 medications? Our directory lists 68 verified providers serving Providence, Rhode Island (194,706 residents · 31.1% adult obesity).

Each clinic below offers GLP-1 weight-loss medications including Ozempic, Wegovy, Mounjaro, and Zepbound. Compare ratings, services, and pricing — then book directly or via our partner directory at GLP1Maps.com.

Find Your Clinic ↓Browse Full Directory →

Top 10 GLP-1 Clinics in Providence

Brown University Health — Obesity Medicine Program — 148 W River St 2nd Floor Suite 1G, Providence, RI | Call for appt. — Center for Medical and Surgical Weight Loss at Brown University Health. Academic obesity medicine specialists, full GLP-1 prescribing, integrated nutrition and behavior support.

SemaglutideTelehealthIn-Person

Providence, RI

4.4

Brower Plastic Surgery — Providence, RI | Call for details — Physician-led semaglutide weight loss under Dr. Brower. Monthly medication pickups, injection training, individualized dose titration over 4–6 months.

OzempicIn-Person

Pricing: Call (consult $100, credited)

More GLP-1 Resources

Independent network of GLP-1 resources serving Providence and patients across the U.S.

What to Look for in a GLP-1 Clinic

Choosing the right GLP-1 provider in Providence matters. Look for clinics that offer:

GLP-1 Medications Explained

GLP-1 receptor agonists work by mimicking a hormone that regulates appetite and blood sugar. The main options:

Cost & Insurance in Rhode Island

RI Medicaid covers GLP-1 for diabetes.

For state regulation info, see the Rhode Island Medical Board.

Frequently Asked Questions

How many GLP-1 clinics are in Providence?

Our directory lists 68 verified GLP-1 clinics in the Providence area, with rankings based on patient reviews, services offered, and verified provider status.

Does insurance cover GLP-1 medications in Rhode Island?

RI Medicaid covers GLP-1 for diabetes.

Are compounded GLP-1 medications still available?

Following the FDA's April 2026 503B ruling, compounded semaglutide and tirzepatide are no longer available from most U.S. pharmacies. Most clinics now prescribe FDA-approved Ozempic, Wegovy, Mounjaro, or Zepbound.